{"DataElement":{"publicId":"14569120","version":"1","preferredName":"Disease Response Domain Cornell Assessment of Pediatric Delirium Score","preferredDefinition":"The Cornell Assessment of Pediatric Delirium (CAPD) assessment Score.","longName":"RS_RSORRES_CAPDRES","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"14569119","version":"1","preferredName":"Disease Response Domain Cornell Assessment of Pediatric Delirium","preferredDefinition":"A domain for disease response evaluations.:A rapid screen for delirium in the pediatric critical care setting that uses observation of consciousness, cognition, orientation, psychomotor activity and affect/distress. It is for use with critically ill pediatric patients, from newborns up to 21 years of age, and may be used in both developmentally normal and delayed patients.","longName":"6608777v1.00:14569118v1.00","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"6608777","version":"1","preferredName":"Disease Response Domain","preferredDefinition":"A domain for disease response evaluations.","longName":"C107097","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Response Domain","conceptCode":"C107097","definition":"A domain for disease response evaluations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F6DD03A-0CB9-71AE-E053-F662850AB42C","latestVersionIndicator":"Yes","beginDate":"2019-01-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-14","modifiedBy":"ONEDATA","dateModified":"2019-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"14569118","version":"1","preferredName":"Cornell Assessment of Pediatric Delirium","preferredDefinition":"A rapid screen for delirium in the pediatric critical care setting that uses observation of consciousness, cognition, orientation, psychomotor activity and affect/distress. It is for use with critically ill pediatric patients, from newborns up to 21 years of age, and may be used in both developmentally normal and delayed patients.","longName":"C201866","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cornell Assessment of Pediatric Delirium","conceptCode":"C201866","definition":"A rapid screen for delirium in the pediatric critical care setting that uses observation of consciousness, cognition, orientation, psychomotor activity and affect/distress. It is for use with critically ill pediatric patients, from newborns up to 21 years of age, and may be used in both developmentally normal and delayed patients.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"087A9F0D-1B00-15EC-E063-731AD00A9BD7","latestVersionIndicator":"Yes","beginDate":"2023-10-24","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-10-24","modifiedBy":"MMADDINENI","dateModified":"2023-10-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"087A9F0D-1B01-15EC-E063-731AD00A9BD7","latestVersionIndicator":"Yes","beginDate":"2023-10-24","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-10-24","modifiedBy":"MMADDINENI","dateModified":"2024-01-11","changeDescription":null,"administrativeNotes":"10/24/2023: Created DEC(CADSR0002962) -MM","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"14569113","version":"1","preferredName":"Cornell Assessment of Pediatric Delirium Score","preferredDefinition":"A rapid screen for delirium in the pediatric critical care setting that uses observation of consciousness, cognition, orientation, psychomotor activity and affect/distress. It is for use with critically ill pediatric patients, from newborns up to 21 years of age, and may be used in both developmentally normal and delayed patients._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"14569113v1.00","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Less than 9 (Grade 1 ICANS)","valueDescription":null,"ValueMeaning":{"publicId":"14569114","version":"1","preferredName":"Immune Effector Cell Associated Neurotoxicity Syndrome Grade 1","longName":"14569114v1.00","preferredDefinition":"Immune effector cell-associated neurotoxicity syndrome (ICANS) characterized by an immune-effector cell-associated encephalopathy (ICE) tool score of 7, 8, or 9, and the ability of the affected individual to awaken spontaneously.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune Effector Cell Associated Neurotoxicity Syndrome Grade 1","conceptCode":"C188936","definition":"Immune effector cell-associated neurotoxicity syndrome (ICANS) characterized by an immune-effector cell-associated encephalopathy (ICE) tool score of 7, 8, or 9 (for adults and children over 12), or a Cornell Assessment of Pediatric Delirium (CAPD) score of less than 9 (for children 12 and under), and the ability of the affected individual to awaken spontaneously.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"087A896F-C9FA-12F9-E063-731AD00A3989","latestVersionIndicator":"Yes","beginDate":"2023-10-24","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-10-24","modifiedBy":"KUMMEROA","dateModified":"2023-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"087A896F-C9FE-12F9-E063-731AD00A3989","beginDate":"2023-10-24","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-10-24","modifiedBy":"MMADDINENI","dateModified":"2023-10-24","deletedIndicator":"No"},{"value":"Less than 9 (Grade 2 ICANS)","valueDescription":null,"ValueMeaning":{"publicId":"14569115","version":"1","preferredName":"Immune Effector Cell Associated Neurotoxicity Syndrome Grade 2","longName":"14569115v1.00","preferredDefinition":"Immune effector cell-associated neurotoxicity syndrome (ICANS) characterized by an immune-effector cell-associated encephalopathy (ICE) tool score of 3, 4, 5, or 6, and the ability of the affected individual to awaken to voice commands.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune Effector Cell Associated Neurotoxicity Syndrome Grade 2","conceptCode":"C188937","definition":"Immune effector cell-associated neurotoxicity syndrome (ICANS) characterized by an immune-effector cell-associated encephalopathy (ICE) tool score of 3, 4, 5, or 6 (for adults and children over 12), or a Cornell Assessment of Pediatric Delirium (CAPD) score of less than 9 (for children 12 and under), and the ability of the affected individual to awaken to voice commands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"087A896F-C9FB-12F9-E063-731AD00A3989","latestVersionIndicator":"Yes","beginDate":"2023-10-24","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-10-24","modifiedBy":"KUMMEROA","dateModified":"2023-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"087A896F-C9FF-12F9-E063-731AD00A3989","beginDate":"2023-10-24","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-10-24","modifiedBy":"MMADDINENI","dateModified":"2023-10-24","deletedIndicator":"No"},{"value":"Greater than or equal to 9 (Grade 3 ICANS)","valueDescription":null,"ValueMeaning":{"publicId":"14569116","version":"1","preferredName":"Immune Effector Cell Associated Neurotoxicity Syndrome Grade 3","longName":"14569116v1.00","preferredDefinition":"Immune effector cell-associated neurotoxicity syndrome (ICANS) characterized by an immune-effector cell-associated encephalopathy (ICE) tool score of 0, 1, or 2, the ability of the affected individual to awaken only to tactile stimulus, clinical focal or generalized seizures that resolve rapidly, or non-convulsive seizures detected by electroencephalography (EEG) that resolve with intervention, and local cerebral edema evident on neuroimaging.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune Effector Cell Associated Neurotoxicity Syndrome Grade 3","conceptCode":"C188939","definition":"Immune effector cell-associated neurotoxicity syndrome (ICANS) characterized by an immune-effector cell-associated encephalopathy (ICE) tool score of 0, 1, or 2 (for adults and children over 12), or a Cornell Assessment of Pediatric Delirium (CAPD) score of greater than or equal to 9 (for children 12 and under), the ability of the affected individual to awaken only to tactile stimulus, clinical focal or generalized seizures that resolve rapidly, or non-convulsive seizures detected by electroencephalography (EEG) that resolve with intervention, and local cerebral edema evident on neuroimaging.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"087A896F-C9FC-12F9-E063-731AD00A3989","latestVersionIndicator":"Yes","beginDate":"2023-10-24","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-10-24","modifiedBy":"KUMMEROA","dateModified":"2023-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"087A896F-CA00-12F9-E063-731AD00A3989","beginDate":"2023-10-24","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-10-24","modifiedBy":"MMADDINENI","dateModified":"2023-10-24","deletedIndicator":"No"},{"value":"Unable to perform assessment (Grade 4 ICANS)","valueDescription":null,"ValueMeaning":{"publicId":"14569117","version":"1","preferredName":"Immune Effector Cell Associated Neurotoxicity Syndrome Grade 4","longName":"14569117v1.00","preferredDefinition":"Immune effector cell-associated neurotoxicity syndrome (ICANS) characterized by an immune-effector cell-associated encephalopathy (ICE) tool score of 0, the inability of the affected individual to be arousable without vigorous or repetitive tactile stimuli, life-threatening prolonged (greater than 5 minutes) seizures, or repetitive clinical or electroencephalographically-detected seizures without ever returning to baseline, deep focal motor weakness, diffuse cerebral edema evident on neuroimaging, decerebrate or decorticate posturing, cranial nerve VI palsy, papilledema or Cushing's triad (bradycardia, hypertension, respiratory depression).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune Effector Cell Associated Neurotoxicity Syndrome Grade 4","conceptCode":"C188940","definition":"Immune effector cell-associated neurotoxicity syndrome (ICANS) characterized by an immune-effector cell-associated encephalopathy (ICE) tool score of 0 or if the ICE scale cannot be performed (for adults and children over 12), or if the Cornell Assessment of Pediatric Delirium (CAPD) scale cannot be performed (for children 12 and under), the inability of the affected individual to be arousable without vigorous or repetitive tactile stimuli, life-threatening prolonged (greater than 5 minutes) seizures, or repetitive clinical or electroencephalographically-detected seizures without ever returning to baseline, deep focal motor weakness, diffuse cerebral edema evident on neuroimaging, decerebrate or decorticate posturing, cranial nerve VI palsy, papilledema or Cushing's triad (bradycardia, hypertension, respiratory depression).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"087A896F-C9FD-12F9-E063-731AD00A3989","latestVersionIndicator":"Yes","beginDate":"2023-10-24","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-10-24","modifiedBy":"KUMMEROA","dateModified":"2023-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"087A896F-CA01-12F9-E063-731AD00A3989","beginDate":"2023-10-24","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-10-24","modifiedBy":"MMADDINENI","dateModified":"2023-10-24","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"14569112","version":"1","preferredName":"Cornell Assessment of Pediatric Delirium Score","preferredDefinition":"A rapid screen for delirium in the pediatric critical care setting that uses observation of consciousness, cognition, orientation, psychomotor activity and affect/distress. It is for use with critically ill pediatric patients, from newborns up to 21 years of age, and may be used in both developmentally normal and delayed patients._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"14569112v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cornell Assessment of Pediatric Delirium","conceptCode":"C201866","definition":"A rapid screen for delirium in the pediatric critical care setting that uses observation of consciousness, cognition, orientation, psychomotor activity and affect/distress. It is for use with critically ill pediatric patients, from newborns up to 21 years of age, and may be used in both developmentally normal and delayed patients.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"087A7D79-A94A-10FB-E063-731AD00AD875","latestVersionIndicator":"Yes","beginDate":"2023-10-24","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-10-24","modifiedBy":"MMADDINENI","dateModified":"2023-10-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"087A7D79-A94B-10FB-E063-731AD00AD875","latestVersionIndicator":"Yes","beginDate":"2023-10-24","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-10-24","modifiedBy":"MMADDINENI","dateModified":"2024-01-11","changeDescription":null,"administrativeNotes":"10/24/2023: Created VD(CADSR0002962)-MM","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What is the Cornell Assessment of Pediatric Delirium (CAPD) assessment score?","url":null,"context":"COG"},{"name":"COG TEXT 1","type":"Alternate Question Text","description":"What is the CAPD assessment score?","url":null,"context":"COG"},{"name":"COG TEXT 2","type":"Alternate Question Text","description":"CAPD assessment score","url":null,"context":"COG"},{"name":"COG TEXT 3","type":"Alternate Question Text","description":"CAPD score","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"087AB695-16BA-19EF-E063-731AD00A5703","latestVersionIndicator":"Yes","beginDate":"2023-10-24","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-10-24","modifiedBy":"MMADDINENI","dateModified":"2024-01-11","changeDescription":null,"administrativeNotes":"10/24/2023: Created CDE(CADSR0002962)-MM","unresolvedIssues":null,"deletedIndicator":"No"}}